Plasma Fractionation Market Analysis
The global plasma fractionation market is predicted to grow at a healthy 6.5% CAGR between 2018- 2023, as per the recent analysis by Market Research Future (MRFR). Plasma is a blood component that is derived by plasmapheresis from whole blood and used in different medical and therapeutic applications. It is a source of different proteins of which just a few are useful to produce therapeutic plasma products. The process to separate, extract, and purify these proteins from the plasma is known as the fractionation process. This process is based upon various criteria like temperature, product solubility, and their chemical & physical conditions like ionic strengths and pH levels. Protease inhibitors, albumin, coagulation factor concentrates, immunoglobulin, and others are the different types of plasma fractionation products.
Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7397
Various factors are propelling the global plasma fractionation market growth. As per the latest MRFR report, such factors include increasing use of immunoglobulin in different therapeutic areas, a rise in plasma collection, growing use of alpha-1-antitrypsin, and an increase in plasma collection centers. Additional factors adding market growth include the rising prevalence of autoimmune and respiratory disorders, technological advances, and rising geriatric population.
On the contrary, unfavorable reimbursement policies, the high price of advanced products, the effect of the COVID-19 outbreak, and the availability of recombinant alternatives are factors that may limit the global plasma fractionation market growth over the forecast period.
Plasma Fractionation Market Segmentation
The MRFR report offers an inclusive segmental analysis of the global plasma fractionation market report based on end user, application, and product.
Based on product, the plasma fractionation market has been segmented into immunoglobulin, protease inhibitors, coagulation factor concentrates, albumin, and others. The immunoglobulin segment is again segmented into subcutaneous immunoglobulin (SCIG), intravenous immunoglobulin (IVIG), and others. The coagulation factor is again segmented into factor XIII, fibrinogen concentrates, prothrombin complex concentrate, von willebrand factor, factor IX, and factor VIII. Of these, the immunoglobulin segment will lead the market over the forecast period.
Based on application, the plasma fractionation market has been segmented into hemato-oncology, pulmonology, rheumatology, critical care, neurology, hematology, immunology, and others. Among these, the neurology segment will dominate the market during the forecast period.
Based on end user, the plasma fractionation market has been segmented into clinical research laboratories, academic institutes, hospitals and clinics, & others. Among these, hospitals & clinics will have a major share in the market over the forecast period.
Plasma Fractionation Market Regional Analysis
Based on the region, the global plasma fractionation market report covers the growth opportunities and recent trends across the Americas, Europe, the Asia Pacific, & the Middle East and Africa. Of these, the Americas will spearhead the market over the forecast period. Rising cases of immunodeficiency disorders coupled with the presence of top market players are adding to the global plasma fractionation market growth in the region.
The global plasma fractionation market in Europe is predicted to have the second-largest share over the forecast period. Surging research and development investments & increasing technological advances are adding to the global plasma fractionation market growth in the region.
The global plasma fractionation market in the APAC region is predicted to grow at a fast pace over the forecast period. Rising healthcare expenditures is adding to the global plasma fractionation market growth in the region.
The global plasma fractionation market in the MEA is predicted to have the smallest share during the forecast period due to the inadequate economic development, especially in the African region.
Plasma Fractionation Market Key Players
Eminent players in the plasma fractionation market report include Shire, Shanghai RAAS, Octapharma AG, Japan Blood Products Organization,LFB Group, Kedrion S.p.A, Grifols, S.A., China Biologic Products Holdings, Green Cross Corporation, CSL Limited, Inc., Biotest AG, and Bio Products Laboratory (BPL).
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Macroeconomic Indicators
4.5 Trends & Assessment
Chapter 5. Market Factor Analysis
…TOC Continued
LIST OF TABLES
Table 1 Plasma Fractionation Market Synopsis, 2018–2023
Table 2 Plasma Fractionation Market Estimates And Forecast, 2018–2023 (USD Million)
Table 3 Global Plasma Fractionation Market, By Region, 2018–2023 (USD Million)
Table 4 Global Plasma Fractionation Market, By Product, 2018–2023 (USD Million)
Table 5 Global Plasma Fractionation Market, By Application, 2018–2023 (USD Million)
Table 6 Global Plasma Fractionation Market, End User, 2018–2023 (USD Million)
…Continued
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Global Plasma Fractionation Market
Figure 3 Market Dynamics For Global Plasma Fractionation Market
Figure 4 Plasma Fractionation Market Share, By Product, 2017
Figure 5 Plasma Fractionation Market Share, By Application, 2017
Figure 6 Plasma Fractionation Market Share, End User, 2017
…Continued
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/plasma-fractionation-market-7397
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
